Search
Have an existing account?
Sign In
ClearBridge Small Cap Strategy Q1 2025 Commentary
By Albert Grosman & Brian Lund, CFA Market Overview Despite an optimistic start to the year, the threat of tariffs and trade policy changes under the new Trump administration and…
Editor's Pick
Oxford Lane Capital: Incredible Distributions Meet Rising Recession Risk (NASDAQ:OXLC)
This article was written byFollowBram de Haas brings 15 years of investing experience to the table and has over 5…
SIGA Technologies: Asymmetric Upside, If 2025 Goes Right (NASDAQ:SIGA)
This article was written byFollowWith a background as an RN and an MBA, I analyze healthcare and tech stocks by…
3 Solid Reasons Why VICI Properties Is A Buy
This article was written byFollowI am a CFA charterholder and a CIPM certificant. Professionally, I assist firms comply with the…
Hydro One Stock: A Strong Q4, But Still Too Expensive (TSX:H:CA)
This article was written byFollowI'm an insurance Case Manager with a deep interest in investing. My investment philosophy is all…
CIO Notebook: Risk Assets Under Pressure As Trump Expands Tariffs
This article was written byFollowNeuberger Berman, founded in 1939, is a private, independent, employee-owned investment manager. The firm manages a…
IonQ Stock Is Trading At Dangerous, Speculation Level Valuations (NYSE:IONQ)
This article was written byFollowProviding alpha-generating investment ideas. I am an independent investor managing my family's portfolio, primarily via a…
Citizens Financial Group: Below Average Fundamentals But Also Cheap
This article was written byFollowHello, my name is Bank Stock Insights. My journey in the finance world began with a…
Gorilla Technology Stock Earnings: Anticlimax (NASDAQ:GRRR)
This article was written byFollowMichael Wiggins De Oliveira is an inflection investor. This means buying into cheap companies at the…
Puma SE: Undervalued With Tailwinds Ahead (OTCMKTS:PUMSY)
This article was written byFollowI am a financial writer who selects and analyzes high quality stocks with great risk/reward propositions.…
Eli Lilly Vs. Novo Nordisk: Which Is The Better Bargain For Investors (NYSE:NVO)
This article was written byFollowWith over two decades of dedicated experience in investment, Allka Research has been a guiding force…
Altria: 9%+ Stock Price Appreciation Potential In 2025 On Top Of Dividends (NYSE:MO)
This article was written byFollowI am a young private investor seeking to find advice and knowledge through my journey in…
Debunking Preferred-Stock ETFs Part 3: SPFF’s Portfolio Breakdown
This article was written byFollowArbitrage Trader, aka Denislav Iliev has been day trading for 15+ years and leads a team…